Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging.
Where this comes from
- Record sourced from PubMed, PMID 26226362.
- Also identified by DOI 10.1371/journal.pone.0134457 and PMC identifier 4520668.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.
Medical subject headings
- Dopamine Plasma Membrane Transport Proteins
- Iodine Radioisotopes
- Nortropanes
- Parkinsonian Disorders
- Patient Satisfaction
- Tomography, Emission-Computed, Single-Photon